A 70% Ethanol Neorhodomela munita Extract Attenuates RANKL-Induced Osteoclast Activation and H2O2-Induced Osteoblast Apoptosis In Vitro

Seongtae Jeong,Il-Kwon Kim,Hanbyeol Moon,Hojin Kim,Byeong-Wook Song,Jung-Won Choi,Sang Woo Kim,Seahyoung Lee,Dong-Sik Chae,Soyeon Lim
DOI: https://doi.org/10.3390/molecules29081741
IF: 4.6
2024-04-12
Molecules
Abstract:The rapid aging of the population worldwide presents a significant social and economic challenge, particularly due to osteoporotic fractures, primarily resulting from an imbalance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation. While conventional therapies offer benefits, they also present limitations and a range of adverse effects. This study explores the protective impact of Neorhodomela munita ethanol extract (EN) on osteoporosis by modulating critical pathways in osteoclastogenesis and apoptosis. Raw264.7 cells and Saos-2 cells were used for in vitro osteoclast and osteoblast models, respectively. By utilizing various in vitro methods to detect osteoclast differentiation/activation and osteoblast death, it was demonstrated that the EN's potential to inhibit RANKL induced osteoclast formation and activation by targeting the MAPKs-NFATc1/c-Fos pathway and reducing H2O2-induced cell death through the downregulation of apoptotic signals. This study highlights the potential benefits of EN for osteoporosis and suggests that EN is a promising natural alternative to traditional treatments.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem this paper attempts to address is the exploration of the potential role of Neorhodomela munita ethanol extract (EN) in regulating osteoclast differentiation and activation, as well as protecting osteoblasts from apoptosis, with the aim of finding a natural alternative to overcome the side effects of traditional osteoporosis treatments. Specifically, the study investigates the effects of EN on RANKL-induced osteoclast differentiation and activation through in vitro experiments, and evaluates whether EN can mitigate H2O2-induced osteoblast death. The research indicates that EN can reduce osteoclast formation and activation by inhibiting the MAPKs-NFATc1/c-Fos signaling pathway, and decrease osteoblast death by downregulating apoptotic signals. These findings suggest that EN may be a promising natural alternative therapy for the treatment of osteoporosis.